ATS Philosophy
Our Mission
ATS strives to become the leading edge, eco-friendly biotechnology company focused on the discovery, development and commercialization of hydrogel-based cryotherapeutics that will assist in Advanced Treatment Solutions for injuries, pain and disease management.
Our Values
Customer Focused
Respect for Others
Improvement and Innovation
Accountability
Sense of Urgency
Team Work
Environmental Focus
Opportunity
The significance of the pain and inflammation management problem is exemplified in the size and continued growth of the market. The estimated total serviceable Global Market for pain and inflammatory management products is $55.8 billion USD and is growing at a rate of approximately 5% per year. The concept of ATS Biotech’s flagship and other industry-revolutionizing products are based on simple, age-old modalities: cryotherapy and compression.
ATS Strategy
ATS Biotech’s product pipeline is geared to address a wide range of unmet needs. Our research and development strategy provides for the innovation of non-drug related, user- and eco-friendly, affordable and functional quality products. The ATS commercialization strategy will leverage these characteristics, ensuring a sustainable consumer-product business.
Fostering a Global Network of celebrities, athletes and research leaders enables ATS to maximize the exposure and development of its technology. It is our grass-roots strategy that permits ATS to deliver high quality and efficacious products to the worldwide consumer market.